Inactive

Notice of Intent to Sole Source HT941024N0123 THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE NON-PERSONAL SERVICES CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency (D... Notice of Intent to Sole Source HT941024N0123 THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE NON-PERSONAL SERVICES CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency (DHA), Healthcare Contracting Division – West / HCD-West / HCD-W, intends to negotiate and award a firm fixed price contract for Fenwal consumables, in accordance with Federal Acquisition Regulation FAR 13.501(a), only one source being available to meet the Government’s needs, to: Fenwal, Inc. 3 Corporate Dr. STE 300 Lake Zurich, IL 60047-8930 The North American Industry Classification System (NAICS) code for this requirement is 325413 – In-Vitro Diagnostic Substance Manufacturing; the business size standard is 1,250 (# of employees). The Product Service Code (PSC) is 6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. The objective of this sole source award is to procure Fenwal Consumables for U.S. Naval Hospital Yokosuka Japan (USNYJ) laboratory Department for use with government owned equipment. Upon evaluation, Fenwal, Inc. was the only market option found to be capable of providing the required items. The requirement will be as follows: Base Year CLIN 0001 – 12.0% SOD CHL SOLN IN 150 ML PLASTI QTY: 08 U/I: CS PART #: 4B7874Q CLIN 0002 – 0.2% DEX & 0.9% SOD CHL SOLUTION 2000ml QTY: 40 U/I: CS PART #: 4B7878 Option Qty One CLIN 1001 – 12.0% SOD CHL SOLN IN 150 ML PLASTI QTY: 08 U/I: CS PART #: 4B7874Q CLIN 1002 – 0.2% DEX & 0.9% SOD CHL SOLUTION 2000ml QTY: 40 U/I: CS PART #: 4B7878 Option Qty Two CLIN 2001 – 12.0% SOD CHL SOLN IN 150 ML PLASTI QTY: 08 U/I: CS PART #: 4B7874Q CLIN 2002 – 0.2% DEX & 0.9% SOD CHL SOLUTION 2000ml QTY: 40 U/I: CS PART #: 4B7878 Option Qty Three CLIN 3001 – 12.0% SOD CHL SOLN IN 150 ML PLASTI QTY: 08 U/I: CS PART #: 4B7874Q CLIN 3002 – 0.2% DEX & 0.9% SOD CHL SOLUTION 2000ml QTY: 40 U/I: CS PART #: 4B7878 Option Qty Four CLIN 4001 – 12.0% SOD CHL SOLN IN 150 ML PLASTI QTY: 08 U/I: CS PART #: 4B7874Q CLIN 4002 – 0.2% DEX & 0.9% SOD CHL SOLUTION 2000ml QTY: 40 U/I: CS PART #: 4B7878 Based on market research, Fenwal, Inc. is the only source that can meet the Government’s minimum requirement for the Fenwal Consumables in support of USNYJ. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required supplies validated by Fenwal, Inc. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Gilberto Esteves at gilberto.a.esteves.civ@health.mil. The closing date for challenges is no later than 0800 Pacific Time, 15 August 2024. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.